Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-25-000373·AMICUS THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Amicus Therapeutics Inc
Common Stock · CUSIP: 03152W109
Event date: 2025-11-28
- Filing-level shares
- 30,871,374
- Percent of class
- 10%
- The Vanguard Group
Shares: 30,871,374 · Class: 10%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000373
- Form type
- SCHEDULE 13G/A
- Filer
- AMICUS THERAPEUTICS, INC.
- CIK
- CIK 1178879
- Filed
- Dec 03, 2025
- Reporting period
- Nov 28, 2025
- Description
- Schedule 13G beneficial ownership